Skip to content
10-Q

Quarterly Report

Lineage Cell Therapeutics, Inc. LCTX

0001193125-25-269599

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 230.33M sh
Shares Diluted Q3 2025 · Sep 30, 2025 228.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 227.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 188.84M sh
Shares Diluted Q3 2025 · Sep 30, 2024 186.86M sh
Capex Q3 2025 · Sep 30, 2025 $123K
Capex Q3 2025 · Sep 30, 2024 $200K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$14.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$16.75M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $40.46M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $45.79M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $27.75M
Stockholders Equity Q3 2025 · Sep 30, 2025 $22.04M
Stockholders Equity Q3 2025 · Dec 31, 2024 $78.38M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.38M
Current Liabilities Q3 2025 · Dec 31, 2024 $13.98M
Total Liabilities Q3 2025 · Sep 30, 2025 $68.84M
Total Liabilities Q3 2025 · Dec 31, 2024 $36.21M
Current Assets Q3 2025 · Sep 30, 2025 $42.26M
Current Assets Q3 2025 · Dec 31, 2024 $51M
Total Assets Q3 2025 · Sep 30, 2025 $89.64M
Total Assets Q3 2025 · Dec 31, 2024 $113.22M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.28
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.08
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.28
Eps Basic Q3 2025 · Sep 30, 2024 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.08
Sga Expense Q3 2025 · Sep 30, 2025 $4.19M
Sga Expense Q3 2025 · Sep 30, 2025 $13.61M
Sga Expense Q3 2025 · Sep 30, 2024 $4.41M
Sga Expense Q3 2025 · Sep 30, 2024 $13.77M
Rd Expense Q3 2025 · Sep 30, 2025 $3.27M
Rd Expense Q3 2025 · Sep 30, 2025 $9.49M
Rd Expense Q3 2025 · Sep 30, 2024 $3.17M
Rd Expense Q3 2025 · Sep 30, 2024 $9.05M
Net Income Q3 2025 · Sep 30, 2025 −$29.78M
Net Income Q3 2025 · Sep 30, 2025 −$64.38M
Net Income Q3 2025 · Sep 30, 2024 −$3.03M
Net Income Q3 2025 · Sep 30, 2024 −$15.34M
Operating Income Q3 2025 · Sep 30, 2025 −$3.79M
Operating Income Q3 2025 · Sep 30, 2025 −$30.07M
Operating Income Q3 2025 · Sep 30, 2024 −$3.84M
Operating Income Q3 2025 · Sep 30, 2024 −$16.37M
Revenue Q3 2025 · Sep 30, 2025 $3.68M
Revenue Q3 2025 · Sep 30, 2025 $7.95M
Revenue Q3 2025 · Sep 30, 2024 $3.78M
Revenue Q3 2025 · Sep 30, 2024 $6.63M
Stock Issued Q3 2025 · Jan 27, 2025 39.47M sh